Skip to main content
Year archive

DR REDDYS LABORATORIES LTD — 2020 filings

All 249 regulatory filings released by DR REDDYS LABORATORIES LTD (RDY) in 2020, sourced directly from the official regulator.

249 Filings
2020 Period
2020 filings (249)
Filing Released Lang
FORM 6-K
Regulatory Filings
2020-12-29 English
Board Meeting Notice - Advertisement
Board/Management Information
2020-12-29 English
FORM 6-K
Regulatory Filings
2020-12-28 English
The trading window for dealing in securities of the Company will be closed from Friday, January 1, 2021 to Sunday, January 31, 2021 (both days inclusive).
Board/Management Information
2020-12-28 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2021 ,inter alia, to consider and approve the Unaudited Financial ....
Board/Management Information
2020-12-28 English
FORM 6-K
Regulatory Filings
2020-12-22 English
Allotment of Equity Shares on exercise of ESOP
Share Issue/Capital Change
2020-12-18 English
FORM 6-K
Regulatory Filings
2020-12-09 English
Secondary Listing of Dr. Reddy's ADRs on NSE IFSC Limited (GIFT City, Gujarat, India)
Capital/Financing Update
2020-12-09 English
Loss of Share Certificate
Regulatory Filings
2020-12-08 English
Issuance of Duplicate Share Certificate
Transaction in Own Shares
2020-12-08 English
Intimation
Capital/Financing Update
2020-12-08 English
6-K Filing
Regulatory Filings
2020-12-08 English
6-K Filing
Regulatory Filings
2020-12-08 English
Dr. Reddy''s and RDIF commence clinical trials for Sputnik V vaccine in India.
Regulatory Filings
2020-12-01 English
FORM 6-K
Regulatory Filings
2020-11-30 English
Dr. Reddy's to acquire select Anti-Allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
Capital/Financing Update
2020-11-28 English
Loss of share certificate
Regulatory Filings
2020-11-26 English
Disclosure of related party transactions for the half year ended September 30, 2020.
Regulatory Filings
2020-11-19 English
Loss of share certificates.
Regulatory Filings
2020-11-19 English
Intimation
Legal Proceedings Report
2020-11-19 English
6-K Filing
Regulatory Filings
2020-11-19 English
FORM 6-K
Regulatory Filings
2020-11-13 English
Dr. Reddy''s Laboratories announces the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) in the U.S. Market
Capital/Financing Update
2020-11-12 English
Loss of Share Certificate
Regulatory Filings
2020-11-09 English
FORM 6-K
Regulatory Filings
2020-10-30 English
Form 6K for Q2 and H1 FY21 filed with US SEC
Interim / Quarterly Report Q2 2021
2020-10-29 English
Newspaper advertisement regarding financial results of Q2 FY2021
Regulatory Filings
2020-10-29 English
FORM 6-K
Interim / Quarterly Report
2020-10-29 English
Dr. Reddy''s partners with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India
Regulatory Filings
2020-10-29 English
6-K Filing
Regulatory Filings
2020-10-29 English
FORM 6-K
Regulatory Filings
2020-10-28 English
FORM 6-K
Regulatory Filings
2020-10-28 English
Issue of duplicate share certificate
Regulatory Filings
2020-10-28 English
Allotment of ESOP and Grant of stock options
Share Issue/Capital Change
2020-10-28 English
Intimation
Interim / Quarterly Report H1 2021
2020-10-28 English
Intimation regarding appointment of new Chief Financial Officer
Board/Management Information
2020-10-28 English
Q2 and H1 FY21 financial results
Interim / Quarterly Report H1 2021
2020-10-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Major Shareholding Notification
2020-10-23 English
Intimation
Regulatory Filings
2020-10-22 English
6-K Filing
Regulatory Filings
2020-10-22 English
Dr. Reddy's announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid AC® in the U.S. Market
Regulatory Filings
2020-10-20 English
6-K Filing
Regulatory Filings
2020-10-20 English
FORM 6-K
Regulatory Filings
2020-10-19 English
Dr. Reddy's and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India
Regulatory Filings
2020-10-17 English
Loss of share certificate.
Regulatory Filings
2020-10-14 English
Compliance Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2020-10-14 English
FORM 6-K
Regulatory Filings
2020-10-13 English
Compliance certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the period ended ....
Regulatory Filings
2020-10-13 English
Dr. Reddy''s to release Q2 FY 21 results on October 28th, 2020 Earnings call slated for October 28th @ 5:30 PM IST / 8:00 AM EDT
Regulatory Filings
2020-10-12 English
Issue of Duplicate Share Certificates
Share Issue/Capital Change
2020-10-08 English
FORM 6-K
Regulatory Filings
2020-10-05 English
Dr. Reddy's Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets
Environmental & Social Information
2020-10-05 English
6-K Filing
Regulatory Filings
2020-10-05 English
Dr. Reddy''s Laboratories announces the launch of a generic version of Sapropterin Dihydrochloride Tablets for Oral Use in the U.S. Market
Regulatory Filings
2020-10-03 English
FORM 6-K
Regulatory Filings
2020-10-01 English
"Dr. Reddy''s Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market"
Regulatory Filings
2020-10-01 English
Loss of Share Certificate
Regulatory Filings
2020-09-30 English
Board Meeting Notice - Advertisement
Regulatory Filings
2020-09-29 English
FORM 6-K
Regulatory Filings
2020-09-28 English
6-K Filing
Regulatory Filings
2020-09-28 English
The trading window for dealing in securities of the Company will be closed from Thursday, October 1, 2020 and ending on Friday, October 30, 2020 (both days inclusive).
Regulatory Filings
2020-09-27 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2020 ,inter alia, to consider and approve Unaudited Financial ....
Regulatory Filings
2020-09-27 English
Dr. Reddy''s Laboratories announces the launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market
Regulatory Filings
2020-09-26 English
FORM 6-K
Regulatory Filings
2020-09-25 English
Dr. Reddy''s announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market
Regulatory Filings
2020-09-25 English
Loss of Share Certificates
Regulatory Filings
2020-09-24 English
FORM 6-K
Regulatory Filings
2020-09-23 English
ESOP allotment intimation
Share Issue/Capital Change
2020-09-23 English
FORM 6-K
Regulatory Filings
2020-09-17 English
Dr. Reddy''s Laboratories announces settlement of U.S. Revlimid® (lenalidomide) Capsules patent litigation with Celgene, a Bristol Myers Squibb Company
Regulatory Filings
2020-09-17 English
Dr. Reddy's announces the launch of Over-the- Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrand equivalent of Pataday®, the Eye Allergy Drop ....
Regulatory Filings
2020-09-17 English
FORM 6-K
Regulatory Filings
2020-09-16 English
RDIF and Dr. Reddy's to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India
Capital/Financing Update
2020-09-16 English
Issue of Duplicate Share Certificate
Share Issue/Capital Change
2020-09-14 English
Press Releases on 'Dr. Reddy''s Laboratories announces the launch of Redyx in India.' and 'Dr. Reddy''s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel ....
Regulatory Filings
2020-09-09 English
6-K Filing
Regulatory Filings
2020-09-09 English
FORM 6-K
Regulatory Filings
2020-09-08 English
Dr. Reddy''s Laboratories announces the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market.
Regulatory Filings
2020-09-07 English
FORM 6-K
Regulatory Filings
2020-09-03 English
Dr. Reddy''s Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market
Regulatory Filings
2020-09-03 English
FORM 6-K
Regulatory Filings
2020-08-28 English
Intimation
Regulatory Filings
2020-08-28 English
Intimation
Regulatory Filings
2020-08-28 English
FORM 6-K
Regulatory Filings
2020-08-27 English
Dr. Reddy''s Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market
Regulatory Filings
2020-08-27 English
FORM 6-K
Regulatory Filings
2020-08-19 English
Dr. Reddy''s Laboratories announces the launch of AVIGAN® (Favipiravir) in India.
Regulatory Filings
2020-08-19 English
FORM 6-K
Regulatory Filings
2020-08-17 English
Allotment of Equity Shares on exercise of ESOP
Share Issue/Capital Change
2020-08-17 English
Loss of share certificate
Regulatory Filings
2020-08-11 English
FORM 6-K
Regulatory Filings
2020-08-11 English
Dr. Reddy''s Laboratories announces the First-to-Market launch of the generic version of Ciprodex® (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market.
Regulatory Filings
2020-08-11 English
FORM 6-K
Declaration of Voting Results & Voting Rights Announcements
2020-08-03 English
Issue of Duplicate Share Certificates
Regulatory Filings
2020-07-31 English
FORM 6-K
Regulatory Filings
2020-07-31 English
Outcome of 36th Annual General Meeting & Voting results
Declaration of Voting Results & Voting Rights Announcements
2020-07-30 English
Outcome of 36th Annual General Meeting & Voting results
Declaration of Voting Results & Voting Rights Announcements
2020-07-30 English
Newspaper publication - Q1 FY21 financial results
Earnings Release Q1 2021
2020-07-30 English
Intimation regarding filing of Form 6-K for the quarter ended June 30, 2020
Interim / Quarterly Report Q1 2021
2020-07-30 English
FORM 6-K
Regulatory Filings
2020-07-29 English
FORM 6-K
Interim / Quarterly Report
2020-07-29 English
Outcome of Board Meeting- Unaudited Financial Results for the quarter ended June 30, 2020
Interim / Quarterly Report Q1 2021
2020-07-29 English
FORM 6-K
Regulatory Filings
2020-07-27 English
Dr. Reddy''s Laboratories received approval of XEGLYZE™ (abametapir) lotion, 0.74%, in the U.S.
Regulatory Filings
2020-07-27 English
FORM 6-K
Regulatory Filings
2020-07-20 English
Earnings call intimation Q1 FY21
Earnings Release Q1 2021
2020-07-20 English
Loss of Share Certificate.
Regulatory Filings
2020-07-16 English
FORM 6-K
Regulatory Filings
2020-07-14 English
Press Release
Regulatory Filings
2020-07-14 English
FORM 6-K
AGM Information
2020-07-08 English
Newspaper advertisement
AGM Information
2020-07-07 English
FORM 6-K
AGM Information
2020-07-06 English
Notice of 36th Annual General Meeting (AGM) and Annual Report 2019-20
Annual Report FY 2020
2020-07-06 English
FORM 6-K
Regulatory Filings
2020-07-01 English
Dr. Reddy's partners with FUJIFILM and Global Response Aid for Avigan® (favipiravir), a potential treatment of COVID-19
Capital/Financing Update
2020-07-01 English
FORM 6-K
Regulatory Filings
2020-06-29 English
ESOP allotment intimation
Share Issue/Capital Change
2020-06-27 English
The trading window for dealing in securities of the Company will be closed from Wednesday, July 1, 2020 and ending on Friday, July 31, 2020 (both days inclusive).
Regulatory Filings
2020-06-27 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve the Unaudited Financial ....
Regulatory Filings
2020-06-27 English
FORM 6-K
AGM Information
2020-06-25 English
Newspaper publication on book closure date and date of AGM
AGM Information
2020-06-25 English
FORM 6-K
Regulatory Filings
2020-06-23 English
Revised Press Release with Conference ID
Investor Presentation
2020-06-23 English
Press Release
Investor Presentation
2020-06-23 English
FORM 6-K
Regulatory Filings
2020-06-19 English
Press Release
Regulatory Filings
2020-06-19 English
Newspaper advertisement for registration of e-mail address and updation of bank details of shareholders.
Regulatory Filings
2020-06-18 English
FORM 6-K
Regulatory Filings
2020-06-17 English
Intimation of date of Annual General Meeting
AGM Information
2020-06-17 English
Intimation of Book Closure
AGM Information
2020-06-17 English
ESOP intimation
Share Issue/Capital Change
2020-06-17 English
FORM 6-K
Report Publication Announcement
2020-06-16 English
Dr. Reddy''s Laboratories Limited announces filing of Annual Report on Form 20-F
Report Publication Announcement
2020-06-16 English
FORM 20-F
Annual Report FY 2020
2020-06-15 English
FORM 6-K
Regulatory Filings
2020-06-15 English
FORM 6-K
Regulatory Filings
2020-06-15 English
Press Release
Regulatory Filings
2020-06-13 English
Press Release
Regulatory Filings
2020-06-12 English
FORM 6-K
Regulatory Filings
2020-06-10 English
Press Release
Capital/Financing Update
2020-06-10 English
Disclosure of related party transactions for the half year ended March 31, 2020.
Regulatory Filings
2020-06-05 English
FORM 6-K
Regulatory Filings
2020-06-01 English
Intimation
Regulatory Filings
2020-05-30 English
FORM 6-K
Regulatory Filings
2020-05-28 English
Intimation
Regulatory Filings
2020-05-28 English
FORM 6-K
Regulatory Filings
2020-05-22 English
Annual Secretarial Compliance Report
Regulatory Filings
2020-05-22 English
Annual Secretarial Compliance Report
Regulatory Filings
2020-05-22 English
Issue of Duplicate Share Certificate.
Regulatory Filings
2020-05-21 English
Grant of Stock Options
Capital/Financing Update
2020-05-21 English
FORM 6-K
Regulatory Filings
2020-05-21 English
FORM 6-K
Regulatory Filings
2020-05-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group (MUFG)
Major Shareholding Notification
2020-05-21 English
Loss of share certificate
Regulatory Filings
2020-05-20 English
Board meeting outcome
Board/Management Information
2020-05-20 English
Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2020, inter alia, have recommended a final dividend of Rs. 25/- (500%) ....
Annual Report FY 2020
2020-05-20 English
Outcome of Board Meeting - Audited Financial Results for the quarter and year ended March 31, 2020.
Annual Report FY 2020
2020-05-20 English
Outcome of Board Meeting - - Audited Financial Results for the quarter and year ended March 31, 2020.
Annual Report FY 2020
2020-05-20 English
Intimation
Regulatory Filings
2020-05-20 English
Newspaper advertisement for transfer of equity shares to IEPF.
Regulatory Filings
2020-05-19 English
FORM 6-K
Regulatory Filings
2020-05-18 English
Intimation
Legal Proceedings Report
2020-05-16 English
FORM 6-K
Regulatory Filings
2020-05-13 English
Intimation
Regulatory Filings
2020-05-13 English
FORM 6-K
Regulatory Filings
2020-05-08 English
FORM 6-K
Regulatory Filings
2020-05-08 English
Intimation
Regulatory Filings
2020-05-08 English
FORM 6-K
Regulatory Filings
2020-05-07 English
Earnings call notification - Q4 and FY20 results
Earnings Release FY 2020
2020-05-07 English
FORM 6-K
Regulatory Filings
2020-05-06 English
Dr. Reddy''s Laboratories received approval for their NDA, ELYXYB™ (celecoxib oral solution) 25 mg/mL, in the U.S
Regulatory Filings
2020-05-06 English
Dr. Reddy''s Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market
Regulatory Filings
2020-05-06 English
FORM 6-K
Regulatory Filings
2020-05-01 English
Credit Rating
Capital/Financing Update
2020-05-01 English
FORM 6-K
Regulatory Filings
2020-04-29 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2020 ,inter alia, to consider and approve the Audited Financial ....
Regulatory Filings
2020-04-29 English
FORM 6-K
Regulatory Filings
2020-04-27 English
Dr. Reddy''s Laboratories announces the launch of Fenofibrate Tablets USP, in the U.S. Market
Regulatory Filings
2020-04-27 English
As attached
Regulatory Filings
2020-04-21 English
FORM 6-K
Regulatory Filings
2020-04-14 English
Dr. Reddy''s Laboratories announces the launch of an authorized generic version of NitroDur® (nitroglycerin) Transdermal Infusion System in the U.S. Market.'
Regulatory Filings
2020-04-14 English
Dr. Reddy''s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market
Regulatory Filings
2020-04-14 English
FORM 6-K
Regulatory Filings
2020-04-10 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-04-09 English
Reg 7(3) compliance certificate for the half year ended March 31, 2020
Regulatory Filings
2020-04-09 English
Intimation
Regulatory Filings
2020-04-09 English
FORM 6-K
Regulatory Filings
2020-03-27 English
Dr Reddys Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2020, inter alia, to consider and approve the Audited Financial ....
Regulatory Filings
2020-03-27 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2020 ,inter alia, to consider and approve Audited Financial ....
Board/Management Information
2020-03-27 English
Outcome of Board meeting
Capital/Financing Update
2020-03-27 English
FORM 6-K
Regulatory Filings
2020-03-23 English
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/03/2020 ,inter alia, to consider and approve Raising of funds ....
Board/Management Information
2020-03-23 English
FORM 6-K
Regulatory Filings
2020-03-20 English
Press Release
Regulatory Filings
2020-03-20 English
FORM 6-K
Regulatory Filings
2020-03-19 English
Press Release
Regulatory Filings
2020-03-19 English
Loss of Share Certificate
Regulatory Filings
2020-03-18 English
FORM 6-K
Regulatory Filings
2020-03-17 English
Press Release
Capital/Financing Update
2020-03-17 English
FORM 6-K
Regulatory Filings
2020-03-16 English
newspaper advertisement
Regulatory Filings
2020-03-14 English
FORM 6-K
Regulatory Filings
2020-03-12 English
ESOP allotment intimation
Share Issue/Capital Change
2020-03-12 English
FORM 6-K
Regulatory Filings
2020-03-05 English
Intimation
Legal Proceedings Report
2020-03-05 English
FORM 6-K
Regulatory Filings
2020-03-02 English
Intimation - Revised
Regulatory Filings
2020-02-28 English
Issue of Duplicate Share Certificate
Regulatory Filings
2020-02-28 English
Intimation
Regulatory Filings
2020-02-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India
Major Shareholding Notification
2020-02-27 English
FORM 6-K
Regulatory Filings
2020-02-27 English
Press Release
Capital/Financing Update
2020-02-27 English
Intimation
Regulatory Filings
2020-02-27 English
FORM 6-K
Regulatory Filings
2020-02-20 English
Dr Reddys Laboratories Ltd has informed BSE that as under:"Further to our intimations dated August 20, 2019 and February 16, 2020 with regard to the audit of our Formulations Manufacturing ....
Regulatory Filings
2020-02-20 English
Loss of Share Certificate
Regulatory Filings
2020-02-19 English
FORM 6-K
Regulatory Filings
2020-02-18 English
Intimation
Regulatory Filings
2020-02-16 English
FORM 6-K
Regulatory Filings
2020-02-14 English
Loss of Share Certificate
Regulatory Filings
2020-02-14 English
Intimation
Regulatory Filings
2020-02-14 English
SCHEDULE 13G
Major Shareholding Notification
2020-02-13 English
FORM 6-K
Regulatory Filings
2020-02-12 English
Press Release
Capital/Financing Update
2020-02-12 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-07 English
FORM 6-K
Regulatory Filings
2020-02-07 English
Press Release
Capital/Financing Update
2020-02-07 English
Press Release
Regulatory Filings
2020-02-07 English
Intimation regarding filing of Form 6K
Interim / Quarterly Report
2020-02-01 English
FORM 6-K
Interim / Quarterly Report
2020-01-31 English
FORM 6-K
Regulatory Filings
2020-01-30 English
FORM 6-K
Regulatory Filings
2020-01-29 English
Intimation
Regulatory Filings
2020-01-29 English
Newspaper publications financials - Q3 FY20
Report Publication Announcement
2020-01-28 English
6-K
Regulatory Filings
2020-01-27 English
6-K
Earnings Release
2020-01-27 English
Grant of Stock Options
Director's Dealing
2020-01-27 English
Issue of Duplicate Share Certificates
Regulatory Filings
2020-01-27 English
Outcome of Board Meeting - Unaudited Financial Results for the quarter and nine months ended December 31, 2019.
Interim / Quarterly Report 9M 2020
2020-01-27 English
Loss of Share Certificates
Regulatory Filings
2020-01-22 English
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group (MUFG)
Major Shareholding Notification
2020-01-17 English
The Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group (MUFG)
Major Shareholding Notification
2020-01-17 English
FORM 6-K
Regulatory Filings
2020-01-13 English
Press Release
Regulatory Filings
2020-01-13 English
FORM 6-K
Regulatory Filings
2020-01-10 English
Earnings call notification
Earnings Release Q3 2020
2020-01-10 English
FORM 6-K
Regulatory Filings
2020-01-03 English
Outcome of NCLT convened meeting and voting results
Declaration of Voting Results & Voting Rights Announcements
2020-01-03 English